Follow
James Loughman
James Loughman
Technological University Dublin
Verified email at tudublin.ie
Title
Cited by
Cited by
Year
The impact of macular pigment augmentation on visual performance using different carotenoid formulations
J Loughman, JM Nolan, AN Howard, E Connolly, K Meagher, S Beatty
Investigative ophthalmology & visual science 53 (12), 7871-7880, 2012
1632012
The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS
JM Nolan, J Loughman, MC Akkali, J Stack, G Scanlon, P Davison, ...
Vision research 51 (5), 459-469, 2011
1272011
Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study
EE Connolly, S Beatty, DI Thurnham, J Loughman, AN Howard, J Stack, ...
Current eye research 35 (4), 335-351, 2010
1202010
The relationship between macular pigment and visual performance
J Loughman, MC Akkali, S Beatty, G Scanlon, PA Davison, V O’Dwyer, ...
Vision research 50 (13), 1249-1256, 2010
1192010
Smartphone use as a possible risk factor for myopia
S McCrann, J Loughman, JS Butler, N Paudel, DI Flitcroft
Clinical and Experimental Optometry 104 (1), 35-41, 2021
1182021
Changes in intraocular pressure and anterior segment morphometry after uneventful phacoemulsification cataract surgery
I Dooley, S Charalampidou, A Malik, J Loughman, L Molloy, S Beatty
Eye 24 (4), 519-527, 2010
1042010
A review of the evidence germane to the putative protective role of the macular carotenoids for age‐related macular degeneration
S Sabour‐Pickett, JM Nolan, J Loughman, S Beatty
Molecular nutrition & food research 56 (2), 270-286, 2012
1022012
The acceptability and visual impact of 0.01% atropine in a Caucasian population
J Loughman, DI Flitcroft
British Journal of Ophthalmology 100 (11), 1525-1529, 2016
942016
Supplementation with all three macular carotenoids: response, stability, and safety
EE Connolly, S Beatty, J Loughman, AN Howard, MS Louw, JM Nolan
Investigative ophthalmology & visual science 52 (12), 9207-9217, 2011
892011
Parental attitudes to myopia: a key agent of change for myopia control?
S McCrann, I Flitcroft, K Lalor, J Butler, A Bush, J Loughman
Ophthalmic and Physiological Optics 38 (3), 298-308, 2018
852018
Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration
S Sabour-Pickett, S Beatty, E Connolly, J Loughman, J Stack, A Howard, ...
Retina 34 (9), 1757-1766, 2014
822014
Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment
JM Nolan, MC Akkali, J Loughman, AN Howard, S Beatty
Experimental eye research 101, 9-15, 2012
802012
Augmentation of macular pigment following implantation of blue light–filtering intraocular lenses at the time of cataract surgery
JM Nolan, P O'Reilly, J Loughman, J Stack, E Loane, E Connolly, S Beatty
Investigative ophthalmology & visual science 50 (10), 4777-4785, 2009
802009
Novel myopia genes and pathways identified from syndromic forms of myopia
DI Flitcroft, J Loughman, CF Wildsoet, C Williams, JA Guggenheim, ...
Investigative ophthalmology & visual science 59 (1), 338-348, 2018
682018
Macular pigment optical density in an ageing Irish population: The Irish Longitudinal Study on Ageing
JM Nolan, R Kenny, C O’Regan, H Cronin, J Loughman, EE Connolly, ...
Ophthalmic research 44 (2), 131-139, 2010
652010
Relationship between fear of falling and mobility varies with visual function among older adults
OA Donoghue, H Ryan, E Duggan, C Finucane, GM Savva, H Cronin, ...
Geriatrics & gerontology international 14 (4), 827-836, 2014
632014
Macular pigment and its contribution to visual performance and experience
J Loughman, PA Davison, JM Nolan, MC Akkali, S Beatty
Journal of Optometry 3 (2), 74-90, 2010
632010
Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)—study protocol
A Azuara-Blanco, N Logan, N Strang, K Saunders, PM Allen, R Weir, ...
British Journal of Ophthalmology 104 (7), 950-955, 2020
562020
Macular pigment optical density is lower in type 2 diabetes, compared with type 1 diabetes and normal controls
G Scanlon, P Connell, M Ratzlaff, B Foerg, D McCartney, A Murphy, ...
Retina 35 (9), 1808-1816, 2015
502015
Evidence of lower macular pigment optical density in chronic open angle glaucoma
E Igras, J Loughman, M Ratzlaff, R O'Caoimh, C O'Brien
British Journal of Ophthalmology 97 (8), 994-998, 2013
482013
The system can't perform the operation now. Try again later.
Articles 1–20